Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hematologic Neoplasms 2Pancreatic Neoplasms 1Pain, Postoperative 1Pain, Intractable 1Neoplasms 1Neoplasm Metastasis 1Mucositis 1Malignant Female Reproductive System Neoplasm 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Duodenal Neoplasms 1Digestive System Diseases 1Carcinoma, Hepatocellular 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Agnosia 1

Interventions

Specimen Handling 2Palliative Care 2Interviews as Topic 2palbociclib 1neratinib 1Rehabilitation 1Referral and Consultation 1Organizational Objectives 1Methods 1Methadone 1Magnetic Resonance Spectroscopy 1Hydromorphone 1Educational Status 1Early Intervention, Educational 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Female Reproductive System Neoplasm × Hydromorphone × 1 year × Clear all
NCT06525740 2026-03-04

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

Mayo Clinic

Phase 4 Recruiting
140 enrolled

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡